Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;24(6):694-698.
doi: 10.1097/MOT.0000000000000708.

Linking innate immunity and chronic antibody-mediated allograft rejection

Ronald G Gill  1 , Christine M Lin  2
Affiliations
Review

Linking innate immunity and chronic antibody-mediated allograft rejection

Ronald G Gill et al. Curr Opin Organ Transplant. 2019 Dec.

Abstract

Purpose of review: To summarize recent findings linking donor-specific antibodies with innate immunity resulting in chronic allograft rejection.

Recent findings: Studies in recent years highlight the significance of donor-specific antibodies (DSA) in both acute and chronic allograft rejection. Since chronic rejection is the leading cause of graft failure, this review centers on the contribution of three areas of innate immunity of particular recent focus: complement, NK cells, and macrophages. Recent advances indicate the diverse roles that complement components play both in directly initiating allograft injury and indirectly by contributing to enhanced alloreactivity. NK cells also have emerged as an additional innate response that directly links DSA with chronic graft injury. Finally, recent studies identify alternatively activated macrophages as an additional arm of innate immunity contributing to chronic allograft rejection.

Summary: Chronic allograft rejection involves a significant contribution of DSA and differing pathways of the innate immune system. However, key issues remain unresolved. First, it is not always clear which of these varied sources of innate immunity contributing to chronic rejection may be antibody dependent. Moreover, it is not yet clear if these innate pathways represent independent routes that contribute to chronic rejection or rather act in concert to mediate allograft injury.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to declare.

References

    1. Loupy A, Lefaucheur C. Antibody-Mediated Rejection of Solid-Organ Allografts. N Engl J Med 2018, 379:1150–1160.

      ** An outstanding and comprehensive review of pathologic and molecular features of AMR across several organ types

    1. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012, 12:388–399. - PubMed

    1. Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 2018, 18:293–307.

      * An important recent meeting report describing updated criteria for the definition of chronic rejection, AMR, and T cell-mediated rejection.

    1. Schinstock CA, Dadhania DM, Everly MJ, et al. Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study. Transpl Int 2019, 32:502–515. - PMC - PubMed
    1. Wasowska BA, Qian Z, Cangello DL, et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 2001, 71:727–736. - PubMed

Publication types